HUMANIGEN INC - COM NEW (HGEN)

CUSIP: 444863203

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM NEW
Total 13F shares
28,489,986
Share change
-878,376
Total reported value
$85,978,932
Put/Call ratio
64%
Price per share
$3.01
Number of holders
78
Value change
-$4,484,882
Number of buys
35
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 444863203?
CUSIP 444863203 identifies HGEN - HUMANIGEN INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HUMANIGEN INC - COM NEW (HGEN) as of Q1 2022

As of 31 Mar 2022, HUMANIGEN INC - COM NEW (HGEN) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,489,986 shares. The largest 10 holders included Valiant Capital Management, L.P., Murchinson Ltd., BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, COWEN AND COMPANY, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and D. E. Shaw & Co., Inc.. This page lists 78 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.